The Food and Drug Administration's January 2025 draft guidance on AI-enabled medical devices acknowledges that erroneous AI outputs can compromise device reliability and user trust, and it emphasizes a total-product-lifecycle approach spanning development, validation, and postmarket management.

Authors

• Person: Not available Organization: The Journal of Nuclear Medicine
  On Hallucinations in Artificial Intelligence–Generated Content ...

Sources

• On Hallucinations in Artificial Intelligence–Generated Content ... jnm.snmjournals.org The Journal of Nuclear Medicine via serper

Referenced by nodes (1)

• United States Food and Drug Administration entity